Mechanistically, ApoB-containing atherogenic lipoproteins may promote endothelial dysfunction and microvascular injury, amplify systemic inflammation and lipid peroxidation, and perturb monoaminergic signaling and neuroplasticity—pathways long implicated in depression. The gene discussed is APOB; the disease is major depressive disorder.